Nomura Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.3M Buy
1,225,321
+209,900
+21% +$11.4M 0.11% 178
2026
Q1
$63.7M Buy
1,015,421
+108,521
+12% +$8.68M 0.16% 129
2025
Q4
$86.5M Buy
906,900
+26,655
+3% +$2.61M 0.22% 84
2025
Q3
$85.9M Buy
880,245
+3,180
+0.4% +$329K 0.22% 84
2025
Q2
$94.2M Sell
877,065
-273,958
-24% -$27.7M 0.26% 79
2025
Q1
$116M Sell
1,151,023
-178,121
-13% -$17.9M 0.36% 58
2024
Q4
$119M Buy
1,329,144
+155,336
+13% +$13.7M 0.36% 55
2024
Q3
$98.4M Sell
1,173,808
-91,386
-7% -$7.2M 0.3% 73
2024
Q2
$97.3M Sell
1,265,194
-15,122
-1% -$1.11M 0.33% 64
2024
Q1
$87.7M Sell
1,280,316
-181,321
-12% -$11.7M 0.32% 68
2023
Q4
$84.5M Buy
1,461,637
+97,073
+7% +$5.18M 0.35% 62
2023
Q3
$72M Sell
1,364,564
-48,210
-3% -$2.53M 0.34% 62
2023
Q2
$76.4M Buy
1,412,774
+290,239
+26% +$15.2M 0.35% 59
2023
Q1
$56.2M Buy
1,122,535
+461,659
+70% +$21.8M 0.3% 80
2022
Q4
$30.6M Sell
660,876
-208,636
-24% -$9.03M 0.18% 132
2022
Q3
$33.7M Buy
869,512
+44,498
+5% +$1.79M 0.21% 106
2022
Q2
$30.7M Buy
825,014
+137,967
+20% +$5.62M 0.19% 115
2022
Q1
$30.4M Buy
687,047
+101,945
+17% +$4.42M 0.17% 135
2021
Q4
$24.9M Buy
585,102
+26,205
+5% +$1.1M 0.13% 164
2021
Q3
$24.3M Sell
558,897
-230,337
-29% -$10.2M 0.14% 155
2021
Q2
$33.7M Buy
789,234
+48,288
+7% +$2.03M 0.2% 117
2021
Q1
$28.6M Buy
740,946
+105,685
+17% +$4M 0.18% 128
2020
Q4
$22.8M Buy
635,261
+37,724
+6% +$1.36M 0.15% 136
2020
Q3
$22.8M Buy
597,537
+190,078
+47% +$7.32M 0.18% 123
2020
Q2
$14.3M Buy
407,459
+35,353
+10% +$1.27M 0.12% 166
2020
Q1
$12.1M Buy
372,106
+6,058
+2% +$237K 0.13% 169
2019
Q4
$16.6M Sell
366,048
-103,068
-22% -$4.31M 0.15% 149
2019
Q3
$19.1M Buy
469,116
+67,117
+17% +$2.84M 0.18% 124
2019
Q2
$17.3M Sell
401,999
-101,308
-20% -$3.9M 0.17% 126
2019
Q1
$19.3M Sell
503,307
-98,276
-16% -$3.75M 0.19% 110
2018
Q4
$21.3M Sell
601,583
-19,892
-3% -$721K 0.24% 95
2018
Q3
$23.9M Buy
621,475
+94,796
+18% +$3.31M 0.23% 104
2018
Q2
$17.2M Buy
526,679
+281,516
+115% +$8.49M 0.18% 118
2018
Q1
$6.7M Sell
245,163
-22,280
-8% -$606K 0.07% 234
2017
Q4
$6.63M Buy
267,443
+33,792
+14% +$932K 0.08% 229
2017
Q3
$6.82M Buy
233,651
+14,225
+6% +$393K 0.09% 215
2017
Q2
$6.08M Buy
219,426
+5,818
+3% +$154K 0.08% 231
2017
Q1
$5.31M Buy
213,608
+78
+0% +$1.9K 0.07% 266
2016
Q4
$4.62M Buy
213,530
+18,708
+10% +$408K 0.08% 258
2016
Q3
$4.64M Buy
194,822
+38,983
+25% +$930K 0.08% 249
2016
Q2
$3.64M Sell
155,839
-800
-0.5% -$17.3K 0.07% 288
2016
Q1
$2.95M Buy
156,639
+8,040
+5% +$141K 0.06% 313
2015
Q4
$2.74M Sell
148,599
-1,900
-1% -$34K 0.05% 325
2015
Q3
$2.47M Buy
150,499
+8,500
+6% +$145K 0.05% 334
2015
Q2
$2.51M Sell
141,999
-16,800
-11% -$300K 0.05% 333
2015
Q1
$2.82M Sell
158,799
-10,000
-6% -$158K 0.05% 312
2014
Q4
$2.27M Sell
168,799
-3,200
-2% -$40.9K 0.04% 359
2014
Q3
$2.03M Sell
171,999
-500
-0.3% -$6.3K 0.04% 365
2014
Q2
$2.2M Sell
172,499
-9,700
-5% -$126K 0.04% 359
2014
Q1
$2.46M Sell
182,199
-26,200
-13% -$344K 0.05% 338
2013
Q4
$2.5M Sell
208,399
-370
-0.2% -$4.37K 0.05% 335
2013
Q3
$2.45M Sell
208,769
-129,954
-38% -$1.41M 0.05% 331
2013
Q2
$3.14M Buy
+338,723
New +$2.87M 0.06% 311

Other funds holding BSX

Nomura Asset Management's BSX Position: Q2 2026 in Review

Nomura Asset Management increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $11.4M and bringing the position to 1,225,321 shares worth $52.3M. The position accounts for 0.11% of the portfolio, ranked #178.

Nomura Asset Management first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $119M in Q4 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Nomura Asset Management held 1,225,321 shares of Boston Scientific worth $52.3M as of Q2 2026.
  • Nomura Asset Management bought 209,900 Boston Scientific shares in Q2 2026, an estimated $11.4M.
  • Boston Scientific made up 0.11% of Nomura Asset Management's portfolio in Q2 2026, its #178 holding.
  • Nomura Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Nomura Asset Management's Boston Scientific position peaked at $119M in Q4 2024.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.